Noteworthy, PI3K/AKT signaling plays a key role in the pathogenesis of human breast cancer and has been hypothesized to confer resistance to systemic treatments including chemotherapy and HER2-targeted therapy [16, 17]. The gene discussed is ERBB2; the disease is breast cancer.